Understand the source comparison
The Unfiltered Truth About Mitochondrial Supplements vs Research Peptides
Here's the honest answer: oral 'mitochondrial support' supplements sold as CoQ10, PQQ, or NAD+ precursors don't restore mitochondrial function the way research peptides do. Not even close. CoQ10 improves electron transport chain efficiency only if you're clini
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Here's the honest answer: oral 'mitochondrial support' supplements sold as CoQ10, PQQ, or NAD+ precursors don't restore mitochondrial function the way research peptides do. Not even close. CoQ10 improves electron transport chain efficiency only if you're clinically deficient. And deficiency is rare outside genetic mitochondrial disease. PQQ's claimed mitochondrial biogenesis effects in humans are based on one 20-person trial with no replication. Nicotinamide riboside raises NAD+ levels transiently but doesn't address cristae collapse, cardiolipin oxidation, or apoptotic signalling. The structural failures that SS-31, MOTS-c, and humanin specifically target.
- The mechanism matters more than the marketing. Mitochondrial dysfunction isn't an NAD+ shortage. It's a structural breakdown of inner membrane architecture and a failure of quality control systems that remove damaged organelles. Peptides that bind cardiolipin, activate AMPK-driven biogenesis, or block premature apoptosis address root causes. Supplements that raise cofactor levels address downstream symptoms. If your mitochondria are structurally intact, CoQ10 might help. If cristae have collapsed and ATP synthase has dissociated, you need membrane stabilisation. And that requires a compound that reaches the inner mitochondrial matrix at pharmacologically relevant concentration.
- Research-grade peptides aren't available over the counter because they require reconstitution, refrigerated storage, and subcutaneous administration. Barriers that prevent casual use but also ensure the compound reaches target tissue at effective concentration. The regulatory distinction exists for good reason: these are investigational tools, not dietary supplements. The evidence supporting SS-31, MOTS-c, and humanin comes from peer-reviewed trials with mitochondrial biopsy endpoints, electron microscopy imaging, and ATP synthesis assays. Not self-reported energy surveys.